Key Points
- CEO Paul Mann sold 83,758 ASP Isotopes shares at an average price of $3.91, generating $327,493.78. The sale was made to cover tax withholding obligations from vested equity awards, reducing his stake by 0.87%.
- Mann also sold an additional 83,759 shares for $343,411.90 on September 4, while ASPI shares opened at $4.20, up 7.7%.
- ASP Isotopes reported a quarterly loss of $0.28 per share, missing estimates, though revenue of $5.12 million exceeded expectations. Analysts have an average “Hold” rating and a consensus price target of $13.00.
ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) COO Robert Ainscow sold 25,000 shares of the company's stock in a transaction on Wednesday, September 2nd. The shares were sold at an average price of $3.90, for a total transaction of $97,500.00. Following the completion of the transaction, the chief operating officer owned 2,256,879 shares of the company's stock, valued at approximately $8,801,828.10. The trade was a 1.10% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website.
Robert Ainscow also recently made the following trade(s):
- On Monday, June 8th, Robert Ainscow sold 8,438 shares of ASP Isotopes stock. The stock was sold at an average price of $7.00, for a total transaction of $59,066.00.
ASP Isotopes Price Performance
Shares of ASPI opened at $4.20 on Friday. The company has a debt-to-equity ratio of 0.76, a current ratio of 3.87 and a quick ratio of 3.85. ASP Isotopes Inc. has a 1-year low of $3.51 and a 1-year high of $14.49. The stock has a market cap of $643.90 million, a PE ratio of -3.18 and a beta of 3.59. The firm has a fifty day moving average price of $4.37 and a 200 day moving average price of $5.20.
ASP Isotopes (NASDAQ:ASPI - Get Free Report) last issued its quarterly earnings data on Friday, August 14th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.17) by ($0.11). The firm had revenue of $5.12 million for the quarter, compared to analysts' expectations of $4.47 million. ASP Isotopes had a negative return on equity of 64.99% and a negative net margin of 427.98%.
Institutional Trading of ASP Isotopes
Several hedge funds have recently made changes to their positions in the company. State of Wyoming purchased a new stake in shares of ASP Isotopes in the first quarter valued at about $29,000. Quantbot Technologies LP purchased a new position in ASP Isotopes during the third quarter worth about $34,000. BNP Paribas Financial Markets raised its holdings in ASP Isotopes by 84.9% during the second quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company's stock worth $41,000 after purchasing an additional 2,548 shares in the last quarter. Stephens Inc. AR acquired a new stake in ASP Isotopes in the first quarter valued at about $44,000. Finally, Broadhurst Jeffrey B purchased a new stake in ASP Isotopes in the 1st quarter valued at approximately $44,000. Institutional investors and hedge funds own 16.80% of the company's stock.
Wall Street Analysts Forecast Growth
A number of analysts recently issued reports on the company. Wall Street Zen raised ASP Isotopes from a "strong sell" rating to a "sell" rating in a research report on Saturday, August 22nd. Weiss Ratings reiterated a "sell (d-)" rating on shares of ASP Isotopes in a research note on Wednesday, June 24th. Two research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat, ASP Isotopes currently has an average rating of "Hold" and a consensus target price of $13.00.
Check Out Our Latest Analysis on ASP Isotopes
ASP Isotopes Company Profile
(
Get Free Report)
ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
